{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T19:42:18Z","timestamp":1760384538014,"version":"3.32.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2005,10,29]],"date-time":"2005-10-29T00:00:00Z","timestamp":1130544000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1007\/s00213-005-0189-y","type":"journal-article","created":{"date-parts":[[2005,10,28]],"date-time":"2005-10-28T11:28:58Z","timestamp":1130498938000},"page":"422-428","source":"Crossref","is-referenced-by-count":53,"title":["Effects of fluoxetine and buspirone on the panicolytic-like response induced by the activation of 5-HT1A and 5-HT2A receptors in the rat dorsal periaqueductal gray"],"prefix":"10.1007","volume":"183","author":[{"given":"Valqu\u00edria Camin","family":"Bortoli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Regina L\u00facia","family":"Nogueira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"H\u00e9lio","family":"Zangrossi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,10,29]]},"reference":[{"key":"189_CR1","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1159\/000102402","volume":"41","author":"K Amano","year":"1978","unstructured":"Amano K, Tanikawa T, Iseki H, Kawabatake H, Notani M, Kawamura H, Kitamura K (1978) Single neuron analysis of the human midbrain tegmentum. Rostral mecencephalic reticulotomy for pain relief. Appl Neurophysiol 41:66\u201378","journal-title":"Appl Neurophysiol"},{"key":"189_CR2","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1113\/jphysiol.1987.sp016862","volume":"394","author":"R Andrade","year":"1987","unstructured":"Andrade R, Nicoll RA (1987) Pharmacologically distinct actions of serotonin on single pyramidal neurones of the rat hippocampus recorded in vitro. J Physiol 394:99\u00a0124","journal-title":"J Physiol"},{"key":"189_CR3","first-page":"159","volume-title":"Panic disorder. Clinical diagnosis, management and mechanisms","author":"JC Ballenger","year":"1999","unstructured":"Ballenger JC (1999) Selective serotonin reuptake inhibitors (SSRIs) in panic disorder. In: Nutt DJ, Ballenger JC, Lepine J-P (eds) Panic disorder. Clinical diagnosis, management and mechanisms. Martin Dunitz, London, pp 159\u2013178"},{"key":"189_CR4","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/0166-2236(94)90047-7","volume":"17","author":"R Bandler","year":"1994","unstructured":"Bandler R, Shipley MT (1994) Columnar organization in the midbrain periaqueductal gray: modules for emotional expression? Trends Neurosci 17:379\u2013389","journal-title":"Trends Neurosci"},{"key":"189_CR5","first-page":"115","volume":"281","author":"SG Beck","year":"1997","unstructured":"Beck SG, Birnstiel S, Choi KC, Pouliot WA (1997) Fluoxetine selectively alters 5-hydroxytryptamine1A and gamma-aminobutyric acidB receptor-mediated hyperpolarization in area CA1, but not area CA3, hippocampal pyramidal cells. J Pharmacol Exp Ther 281:115\u2013122","journal-title":"J Pharmacol Exp Ther"},{"key":"189_CR6","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1177\/026988119701100111","volume":"11","author":"S Beckett","year":"1997","unstructured":"Beckett S, Marsden CA (1997) The effect of central and systemic injection of the 5-HT1A receptor agonist 8-OHDPAT and the 5-HT1A receptor antagonist WAY100635 on periaqueductal grey-induced defence behaviour. J Psychopharmacol 11:35\u201340","journal-title":"J Psychopharmacol"},{"key":"189_CR7","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1007\/BF02245294","volume":"108","author":"SR Beckett","year":"1992","unstructured":"Beckett SR, Lawrence AJ, Marsden CA, Marshall PW (1992) Attenuation of chemically induced defence response by 5-HT1 receptor agonists administered into the periaqueductal gray. Psychopharmacology 108:110\u2013114","journal-title":"Psychopharmacology"},{"key":"189_CR8","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/0165-6147(94)90315-8","volume":"15","author":"P Blier","year":"1994","unstructured":"Blier P, de Montigny C (1994) Current advances and trends in the treatment of depression. Trends Pharmacol Sci 15:220\u2013226","journal-title":"Trends Pharmacol Sci"},{"key":"189_CR9","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/BF00210830","volume":"92","author":"PJ Conn","year":"1987","unstructured":"Conn PJ, Sanders-Bush E (1987) Central serotonin receptors: effector systems, physiological roles and regulation. Psychopharmacology 92:267\u2013277","journal-title":"Psychopharmacology"},{"key":"189_CR10","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1016\/S0006-3223(98)00285-6","volume":"44","author":"KM Connor","year":"1998","unstructured":"Connor KM, Davidson JRT (1998) Generalized anxiety disorder: neurobiological and pharmacotherapeutic perspectives. Biol Psychiatry 44:1286\u20131294","journal-title":"Biol Psychiatry"},{"key":"189_CR11","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1124\/jpet.103.050534","volume":"306","author":"KJ Damjanoska","year":"2003","unstructured":"Damjanoska KJ, Van de Kar LD, Kindel GH, Zhang Y, D'Souza DN, Garcia F, Battaglia G, Muma NA (2003) Chronic fluoxetine differentially affects 5-hydroxytryptamine (2A) receptor signaling in frontal cortex, oxytocin- and corticotropin-releasing factor-containing neurons in rat paraventricular nucleus. J Pharmacol Exp Ther 306:563\u2013571","journal-title":"J Pharmacol Exp Ther"},{"key":"189_CR12","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1177\/026988119100500414","volume":"5","author":"JFW Deakin","year":"1991","unstructured":"Deakin JFW, Graeff FG (1991) 5-HT and mechanisms of defense. J Psychopharmacol 5:305\u2013315","journal-title":"J Psychopharmacol"},{"issue":"suppl 4","key":"189_CR13","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1097\/00004850-199804004-00005","volume":"13","author":"JA Boer den","year":"1998","unstructured":"den Boer JA, Slaap BR (1998) Review of current treatment in panic disorder. Int Clin Psychopharmacol 13 (suppl 4):S25\u2013S30","journal-title":"Int Clin Psychopharmacol"},{"key":"189_CR14","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/978-1-349-11847-2_7","volume-title":"New concepts in anxiety","author":"J Vry De","year":"1991","unstructured":"De Vry J, Glaser T, Schuurman T, Schreiber R, Traber J (1991) 5-HT1A receptors in anxiety. In: Briley M, File SE (eds) New concepts in anxiety, Macmillan Press, London, pp 94\u2013129"},{"key":"189_CR15","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S0028-3908(02)00340-4","volume":"44","author":"M Elena Castro","year":"2003","unstructured":"Elena Castro M, Diaz A, del Olmo E, Pazos A (2003) Chronic fluoxetine induces opposite changes in G protein coupling at pre and postsynaptic 5-HT1A receptors in rat brain. Neuropharmacology 44:93\u2013101","journal-title":"Neuropharmacology"},{"key":"189_CR16","doi-asserted-by":"publisher","first-page":"114","DOI":"10.2165\/00003495-198632020-00002","volume":"32","author":"KL Goa","year":"1986","unstructured":"Goa KL, Ward A (1986) Buspirone. A preliminary review of its pharmacological properties and therapeutic efficacy as an anxiolytic. Drugs 32:114\u2013129","journal-title":"Drugs"},{"key":"189_CR17","first-page":"307","volume-title":"Handbook of anxiety. The neurobiology of anxiety","author":"FG Graeff","year":"1990","unstructured":"Graeff FG (1990) Brain defense systems and anxiety. In: Roth M, Burrows GD, Noyes R (eds) Handbook of anxiety. The neurobiology of anxiety. Elsevier, Amsterdam, pp 307\u2013354"},{"key":"189_CR18","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s00213-002-1112-4","volume":"163","author":"FG Graeff","year":"2002","unstructured":"Graeff FG (2002) On serotonin and experimental anxiety. Psychopharmacology 163:467\u2013476","journal-title":"Psychopharmacology"},{"key":"189_CR19","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.neubiorev.2003.12.004","volume":"28","author":"FG Graeff","year":"2004","unstructured":"Graeff FG (2004) Serotonin, the periaqueductal gray and panic. Neurosci Biobehav Rev 28:239\u2013259","journal-title":"Neurosci Biobehav Rev"},{"key":"189_CR20","first-page":"879","volume-title":"Textbook of biological psychiatry","author":"FG Graeff","year":"2002","unstructured":"Graeff FG, Zangrossi H Jr (2002) Animal models of anxiety disorders. In: D'Haenen H, den Boer JA, Westenberg H, Willner P (eds) Textbook of biological psychiatry. Wiley, London, pp 879\u2013893"},{"key":"189_CR21","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/0166-4328(93)90097-A","volume":"58","author":"FG Graeff","year":"1993","unstructured":"Graeff FG, Silveira MC, Nogueira RL, Audi EA, Oliveira RM (1993) Role of the amygdala and periaqueductal gray in anxiety and panic. Behav Brain Res 58:123\u2013131","journal-title":"Behav Brain Res"},{"key":"189_CR22","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/S0149-7634(98)00024-4","volume":"23","author":"FG Graeff","year":"1998","unstructured":"Graeff FG, Netto CF, Zangrossi H Jr (1998) The elevated T-maze as an experimental model of anxiety. Neurosci Biobehav Rev 23:237\u2013246","journal-title":"Neurosci Biobehav Rev"},{"key":"189_CR23","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S0304-3940(02)00182-9","volume":"326","author":"JL Griffiths","year":"2002","unstructured":"Griffiths JL, Lovick TA (2002) Co-localization of 5-HT 2A- receptor- and GABA-immunoreactivity in neurones in the periaqueductal grey matter of the rat. Neurosci Lett 326:151\u2013154","journal-title":"Neurosci Lett"},{"key":"189_CR24","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/0014-2999(94)90344-1","volume":"260","author":"R Invernizzi","year":"1994","unstructured":"Invernizzi R, Bramante M, Samanin R (1994) Chronic treatment with citalopram facilitates the effect of a challenge dose on cortical serotonin output: role of presynaptic 5-HT1A receptors. Eur J Pharmacol 260:243\u2013246","journal-title":"Eur J Pharmacol"},{"key":"189_CR25","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/S0091-3057(01)00785-7","volume":"72","author":"CA Jacob","year":"2002","unstructured":"Jacob CA, Cabral AH, Almeida LP, Magierek V, Ramos PL, Zanoveli JM, Landeira-Fernandez J, Zangrossi H Jr, Nogueira RL (2002) Chronic imipramine enhances 5-HT(1A) and 5-HT(2) receptors-mediated inhibition of panic-like behavior in the rat dorsal periaqueductal gray. Pharmacol Biochem Behav 72:761\u2013766","journal-title":"Pharmacol Biochem Behav"},{"key":"189_CR26","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/0165-1781(95)02673-K","volume":"57","author":"F Jenck","year":"1995","unstructured":"Jenck F, Moreau JL, Martin JR (1995) Dorsal periaqueductal gray-induced aversion as a simulation of panic anxiety: elements of face and predictive validity. Psychiatry Res 57:181\u2013191","journal-title":"Psychiatry Res"},{"key":"189_CR27","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S0924-977X(97)00055-2","volume":"8","author":"F Jenck","year":"1998","unstructured":"Jenck F, Moreau JL, Berendsen HH, Boes M, Broekkamp CL, Martin JR, Wichmann J, Van Delft AM (1998) Antiaversive effects of 5HT2C receptor agonists and fluoxetine in a model of panic-like anxiety in rats. Eur Neuropsychopharmacol 8:161\u2013168","journal-title":"Eur Neuropsychopharmacol"},{"key":"189_CR28","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/0031-9384(75)90278-4","volume":"15","author":"RS Kiser","year":"1975","unstructured":"Kiser RS, Lebovitz RM (1975) Monoaminergic mechanisms in aversive brain stimulation. Physiol Behav 15:47\u201353","journal-title":"Physiol Behav"},{"key":"189_CR29","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/0091-3057(78)90008-4","volume":"9","author":"RS Kiser","year":"1978","unstructured":"Kiser RS, German DC, Lebovitz RM (1978) Serotonergic reduction of dorsal central gray area stimulation-produced aversion. Pharmacol Biochem Behav 9:27\u201331","journal-title":"Pharmacol Biochem Behav"},{"key":"189_CR30","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1176\/ajp.119.5.432","volume":"119","author":"DF Klein","year":"1962","unstructured":"Klein DF, Fink M (1962) Psychiatric reaction patterns to imipramine. Am J Psychiatry 119:432\u2013438","journal-title":"Am J Psychiatry"},{"key":"189_CR31","doi-asserted-by":"publisher","first-page":"654","DOI":"10.4088\/JCP.v64n0606","volume":"64","author":"U Lepola","year":"2003","unstructured":"Lepola U, Arato M, Zhu Y, Austin C (2003) Sertraline versus imipramine treatment of comorbid panic disorder and major depressive disorder. J Clin Psychiatry 64:654\u2013662","journal-title":"J Clin Psychiatry"},{"key":"189_CR32","first-page":"1035","volume":"279","author":"Q Li","year":"1996","unstructured":"Li Q, Muma NA, van de Kar LD (1996) Chronic fluoxetine induces a gradual desensitization of 5-HT1A receptors: reductions in hypothalamic and midbrain Gi and G(o) proteins and in neuroendocrine responses to a 5-HT1A agonist. J Pharmacol Exp Ther 279:1035\u20131042","journal-title":"J Pharmacol Exp Ther"},{"key":"189_CR33","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1177\/107385840000600113","volume":"6","author":"TA Lovick","year":"2000","unstructured":"Lovick TA (2000) Panic disorder\u2013a malfunction of multiple transmitter control systems within the midbrain periaqueductal gray matter. Neuroscientist 6:48\u201359","journal-title":"Neuroscientist"},{"key":"189_CR34","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/0165-0327(87)90020-6","volume":"13","author":"RB Lydiard","year":"1987","unstructured":"Lydiard RB, Ballenger JC (1987) Antidepressants in panic disorder and agoraphobia. J Affect Disord 13:153\u2013168","journal-title":"J Affect Disord"},{"key":"189_CR35","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/0031-9384(77)90349-3","volume":"19","author":"RF Marseillan","year":"1977","unstructured":"Marseillan RF (1977) A solid state sine-wave stimulator. Physiol Behav 19:339\u2013340","journal-title":"Physiol Behav"},{"key":"189_CR36","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s002130050299","volume":"131","author":"R Mongeau","year":"1997","unstructured":"Mongeau R, Marsden CA (1997) Effect of imipramine treatments on the 5-HT1A-receptor-mediated inhibition of panic-like behaviours in rats. Psychopharmacology 131:321\u2013328","journal-title":"Psychopharmacology"},{"key":"189_CR37","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3171\/jns.1969.30.1.0014","volume":"30","author":"BS Nashold Jr","year":"1969","unstructured":"Nashold BS Jr, Wilson WP, Slaughter DG (1969) Sensations evoked by stimulation in the midbrain of man. J Neurosurg 30:14\u201324","journal-title":"J Neurosurg"},{"key":"189_CR38","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1176\/appi.ajp.157.9.1423","volume":"157","author":"AA Nierenberg","year":"2000","unstructured":"Nierenberg AA, Farabaugh AH, Alpert JE, Gordon J, Worthington JJ, Rosenbaum JF, Fava M (2000) Timing of onset of antidepressant response with fluoxetine treatment. Am J Psychiatry 157:1423\u20131428","journal-title":"Am J Psychiatry"},{"key":"189_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0091-3057(94)00402-5","volume":"52","author":"RL Nogueira","year":"1995","unstructured":"Nogueira RL, Graeff FG (1995) Role of 5-HT receptor subtypes in the modulation of dorsal periaqueductal gray generated aversion. Pharmacol Biochem Behav 52:1\u20136","journal-title":"Pharmacol Biochem Behav"},{"key":"189_CR40","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1152\/ajplegacy.1962.203.5.803","volume":"203","author":"ME Olds","year":"1962","unstructured":"Olds ME, Olds J (1962) Approach\u2013escape interactions in rat brain. Am J Physiol 203:803\u2013810","journal-title":"Am J Physiol"},{"key":"189_CR41","volume-title":"The rat brain in stereotaxic coordinates","author":"G Paxinos","year":"1997","unstructured":"Paxinos G, Watson C (1997) The rat brain in stereotaxic coordinates, 3rd edn. Academic Press, San Diego","edition":"3rd edn"},{"key":"189_CR42","doi-asserted-by":"publisher","first-page":"118","DOI":"10.2165\/00002018-199716020-00004","volume":"16","author":"JC Pecknold","year":"1997","unstructured":"Pecknold JC (1997) A risk-benefit assessment of buspirone in the treatment of anxiety disorders. Drug Saf 16:118\u2013132","journal-title":"Drug Saf"},{"key":"189_CR43","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S0166-4328(03)00151-7","volume":"147","author":"SC Poltronieri","year":"2003","unstructured":"Poltronieri SC, Zangrossi H Jr, de Barros Viana M (2003) Antipanic-like effect of serotonin reuptake inhibitors in the elevated T-maze. Behav Brain Res 147:185\u2013192","journal-title":"Behav Brain Res"},{"key":"189_CR44","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0022-3565(24)37930-3","volume":"288","author":"DK Raap","year":"1999","unstructured":"Raap DK, Evans S, Garcia F, Li Q, Muma NA, Wolf WA, Battaglia G, Van De Kar LD (1999) Daily injections of fluoxetine induce dose-dependent desensitization of hypothalamic 5-HT1A receptors: reductions in neuroendocrine responses to 8-OH-DPAT and in levels of Gz and Gi proteins. J Pharmacol Exp Ther 288:98\u2013106","journal-title":"J Pharmacol Exp Ther"},{"key":"189_CR45","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/0091-3057(78)90287-3","volume":"9","author":"LC Schenberg","year":"1978","unstructured":"Schenberg LC, Graeff FG (1978) Role of the periaqueductal gray substance in the antianxiety action of benzodiazepines. Pharmacol Biochem Behav 9:287\u2013295","journal-title":"Pharmacol Biochem Behav"},{"key":"189_CR46","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/S0149-7634(01)00060-4","volume":"25","author":"LC Schenberg","year":"2001","unstructured":"Schenberg LC, Bittencourt AS, Sudre EC, Vargas LC (2001) Modeling panic attacks. Neurosci Biobehav Rev 25:647\u2013659","journal-title":"Neurosci Biobehav Rev"},{"key":"189_CR47","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1097\/00004714-199004000-00007","volume":"10","author":"FR Schneier","year":"1990","unstructured":"Schneier FR, Liebowitz MR, Davies SO, Fairbanks J, Hollander E, Campeas R, Klein DF (1990) Fluoxetine in panic disorder. J Clin Psychopharmacol 10:119\u2013121","journal-title":"J Clin Psychopharmacol"},{"key":"189_CR48","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1007\/BF00428199","volume":"85","author":"MT Sch\u00fctz","year":"1985","unstructured":"Sch\u00fctz MT, de Aguiar JC, Graeff FG (1985) Anti-aversive role of serotonin in the dorsal periaqueductal grey matter. Psychopharmacology 85:340\u2013345","journal-title":"Psychopharmacology"},{"key":"189_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1600-0447.1993.tb03405.x","volume":"88","author":"DV Sheehan","year":"1993","unstructured":"Sheehan DV, Raj AB, Harnett-Sheehan K, Soto S, Knapp E (1993) The relative efficacy of high-dose buspirone and alprazolam in the treatment of panic disorder: a double-blind placebo-controlled study. Acta Psychiatr Scand 88:1\u201311","journal-title":"Acta Psychiatr Scand"},{"key":"189_CR50","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/S0028-3908(02)00064-3","volume":"42","author":"C Shen","year":"2002","unstructured":"Shen C, Li H, Meller E (2002) Repeated treatment with antidepressants differentially alters 5-HT1A agonist-stimulated [35S]GTP gamma S binding in rat brain regions. Neuropharmacology 42:1031\u20131038","journal-title":"Neuropharmacology"},{"key":"189_CR51","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/S0091-3057(00)00200-8","volume":"66","author":"M Siemiatkowski","year":"2000","unstructured":"Siemiatkowski M, Sienkiewicz-Jarosz H, Czlonkowska AI, Bidzinski A, Plaznik A (2000) Effects of buspirone, diazepam, and zolpidem on open field behavior, and brain [3H]muscimol binding after buspirone pretreatment. Pharmacol Biochem Behav 66:645\u2013651","journal-title":"Pharmacol Biochem Behav"},{"key":"189_CR52","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/syn.890010103","volume":"1","author":"JS Sprouse","year":"1987","unstructured":"Sprouse JS, Aghajanian GK (1987) Electrophysiological responses of serotoninergic dorsal raphe neurons to 5-HT1A and 5-HT1B agonists. Synapse 1:3\u20139","journal-title":"Synapse"},{"key":"189_CR53","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/S0091-3057(99)00261-0","volume":"65","author":"RC Teixeira","year":"2000","unstructured":"Teixeira RC, Zangrossi H Jr, Graeff FG (2000) Behavioral effects of acute and chronic imipramine in the elevated T-maze model of anxiety. Pharmacol Biochem Behav 65:571\u2013576","journal-title":"Pharmacol Biochem Behav"},{"key":"189_CR54","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/0091-3057(88)90141-4","volume":"30","author":"D Treit","year":"1988","unstructured":"Treit D, Fundytus M (1988) A comparison of buspirone and chlordiazepoxide in the shock-probe\/burying test for anxiolytics. Pharmacol Biochem Behav 30:1071\u20131075","journal-title":"Pharmacol Biochem Behav"},{"key":"189_CR55","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1007\/s002130100698","volume":"155","author":"LC Vargas","year":"2001","unstructured":"Vargas LC, Schenberg LC (2001) Long-term effects of clomipramine and fluoxetine on dorsal periaqueductal grey-evoked innate defensive behaviours of the rat. Psychopharmacology 155:260\u2013268","journal-title":"Psychopharmacology"},{"key":"189_CR56","doi-asserted-by":"crossref","unstructured":"Zanoveli JM, Nogueira RL, Zangrossi H Jr (2005) Chronic imipramine treatment sensitizes 5-HT1A and 5-HT2A receptors in the dorsal periaqueductal gray matter: evidence from the elevated T-maze test of anxiety. Behav Pharmacol (in press)","DOI":"10.1097\/01.fbp.0000179280.05654.5a"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-005-0189-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-005-0189-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-005-0189-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-005-0189-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T07:07:57Z","timestamp":1736060877000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-005-0189-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10,29]]},"references-count":56,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["189"],"URL":"https:\/\/doi.org\/10.1007\/s00213-005-0189-y","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"type":"print","value":"0033-3158"},{"type":"electronic","value":"1432-2072"}],"subject":[],"published":{"date-parts":[[2005,10,29]]}}}